James T. Boyd

3.0k total citations
28 papers, 780 citations indexed

About

James T. Boyd is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, James T. Boyd has authored 28 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Epidemiology. Recurrent topics in James T. Boyd's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (13 papers) and Restless Legs Syndrome Research (6 papers). James T. Boyd is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (13 papers) and Restless Legs Syndrome Research (6 papers). James T. Boyd collaborates with scholars based in United States, Australia and Italy. James T. Boyd's co-authors include Robert W. Hamill, Kathleen A. Maguire‐Zeiss, Timothy R. Mhyre, Krai Chatamra, Janet Benesh, Adriana Pérez, Susan Eaton, Coleen Hall, John T. Slevin and Victor S.C. Fung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Movement Disorders.

In The Last Decade

James T. Boyd

28 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James T. Boyd United States 13 555 182 126 105 97 28 780
Brandon Barton United States 8 662 1.2× 231 1.3× 66 0.5× 54 0.5× 50 0.5× 17 818
G. Gambaccini Italy 12 420 0.8× 155 0.9× 137 1.1× 70 0.7× 110 1.1× 13 677
Eva Schaeffer Germany 18 769 1.4× 209 1.1× 192 1.5× 108 1.0× 223 2.3× 44 1.1k
Jukka Lyytinen Finland 12 778 1.4× 250 1.4× 157 1.2× 77 0.7× 220 2.3× 19 946
Ashok Philip United States 7 273 0.5× 129 0.7× 128 1.0× 32 0.3× 74 0.8× 13 540
Tenghong Lian China 14 385 0.7× 92 0.5× 119 0.9× 113 1.1× 136 1.4× 36 740
Paola Imbriani Italy 17 502 0.9× 302 1.7× 160 1.3× 77 0.7× 107 1.1× 40 790
Sixun Yu China 14 150 0.3× 211 1.2× 230 1.8× 33 0.3× 91 0.9× 31 801
Ewelina Pałasz Poland 8 168 0.3× 256 1.4× 155 1.2× 35 0.3× 118 1.2× 17 587
G. Scigliano Italy 14 490 0.9× 248 1.4× 108 0.9× 50 0.5× 64 0.7× 29 684

Countries citing papers authored by James T. Boyd

Since Specialization
Citations

This map shows the geographic impact of James T. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Boyd more than expected).

Fields of papers citing papers by James T. Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Boyd. The network helps show where James T. Boyd may publish in the future.

Co-authorship network of co-authors of James T. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Boyd. A scholar is included among the top collaborators of James T. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Boyd. James T. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Penar, Paul L., et al.. (2022). Pallidal stimulation-induced psychosis and suicidality in Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 8. 100175–100175. 2 indexed citations
2.
Houston, Emily, et al.. (2021). Telemedicine in Neurology: A Scoping Review of Key Outcomes in Movement Disorders. Telemedicine Journal and e-Health. 28(3). 295–308. 10 indexed citations
3.
Gupta, Deepak, et al.. (2020). Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson’s Disease. Tremor and Other Hyperkinetic Movements. 10(0). 58–58. 19 indexed citations
4.
Boyd, James T., Cindy Zadikoff, Janet Benesh, et al.. (2019). A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies. Clinical Parkinsonism & Related Disorders. 2. 25–34. 3 indexed citations
5.
Fernandez, Hubert H., James T. Boyd, Victor S.C. Fung, et al.. (2018). Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease. Movement Disorders. 33(6). 928–936. 69 indexed citations
6.
Standaert, David G., James T. Boyd, Per Odin, et al.. (2018). Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics. npj Parkinson s Disease. 4(1). 4–4. 9 indexed citations
7.
Chou, Kelvin L., Jordan J. Elm, Catherine L. Wielinski, et al.. (2017). Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377. 137–143. 25 indexed citations
8.
Wills, Anne‐Marie, et al.. (2017). Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort. Journal of Neurology. 264(8). 1746–1753. 32 indexed citations
9.
Leehey, Maureen A., Sheng Luo, Saloni Sharma, et al.. (2017). Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. Neurology. 89(17). 1789–1794. 22 indexed citations
10.
Boyd, James T., Cindy Zadikoff, Janet Benesh, et al.. (2017). Safety and efficacy of levodopa-carbidopa monotherapy in patients with advanced parkinson’s disease. Journal of the Neurological Sciences. 381. 182–183. 3 indexed citations
11.
Ramirez–Zamora, Adolfo, Lucy Gee, James T. Boyd, & José Biller. (2016). Treatment of impulse control disorders in Parkinson’s disease: Practical considerations and future directions. Expert Review of Neurotherapeutics. 16(4). 389–399. 30 indexed citations
12.
Wills, Anne‐Marie, Adriana Pérez, Jue Wang, et al.. (2016). Association Between Change in Body Mass Index, Unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease. JAMA Neurology. 73(3). 321–321. 80 indexed citations
13.
Wangensteen, Kirk J., Edward L. Krawitt, Robert W. Hamill, & James T. Boyd. (2016). Parkinsonism in Patients With Chronic Hepatitis C Treated With Interferons. Clinical Neuropharmacology. 39(1). 1–5. 7 indexed citations
14.
Goudreau, John L., Adriana Pérez, Michael J. Aminoff, et al.. (2016). Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America. Journal of the Neurological Sciences. 366. 74–81. 6 indexed citations
16.
Jacobs, Jesse V., James T. Boyd, Penelope Hogarth, & Fay B. Horak. (2015). Domains and correlates of clinical balance impairment associated with Huntington's disease. Gait & Posture. 41(3). 867–870. 8 indexed citations
17.
Antonini, Angelo, Victor S.C. Fung, James T. Boyd, et al.. (2014). Changes In Troublesome Dyskinesia And Its Relationship With Dose In Advanced Parkinson’s Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel Infusion (P7.071). Neurology. 82(10_supplement). 1 indexed citations
18.
Fang, John Y., Adriana Pérez, Chadwick W. Christine, et al.. (2014). Parkinson's disease severity and use of dopaminergic medications. Parkinsonism & Related Disorders. 21(3). 297–299. 6 indexed citations
19.
Mhyre, Timothy R., James T. Boyd, Robert W. Hamill, & Kathleen A. Maguire‐Zeiss. (2012). Parkinson’s Disease. Sub-cellular biochemistry. 65. 389–455. 294 indexed citations
20.
Boyd, James T. & Ashley A. Weaver. (1967). Spastic paresis in cattle. Veterinary Record. 80(17). 529–530. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026